Biotech Values

[ghmm]

vrtx:

They said they still need to do dose ranging studies on the drug. I don't see how they'll start the combo study in Q4 if this has to be completed first. Perhaps they will just hurry along with a low dose study. I wonder if they have even done invitro tests with this compound and telaprevir.